Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-17

FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application from Alembic Pharmaceuticals Limited to manufacture and market lamotrigine chewable dispersible tablets as a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine Chewable Dispersible (Lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE CHEWABLE DISPERSIBLE)